Ketone Bodies: Universal Cardiac Response to Stress?

Over the past decade, there has been significant interest in the role of ketone bodies (KBs) both within and outside the medical arena because of their reported beneficial effects in the heart.

0 634 0
NT-proBNP Response to Heart Failure Therapies: An Imperfect Surrogate

The validation of natriuretic peptides (NPs)—B-type NP (BNP) and the more stable N-terminal proBNP (NT-proBNP)—as heart failure (HF) biomarkers over the past 3 decades has transformed clinical practice by providing a means to discriminate acute HF from other causes of dyspnea

0 499 0
Colchicine in Acute Coronary Syndrome: When to Commence?

Patients with coronary disease have a life-long increased risk of developing new major adverse cardiovascular events. Depending on co-morbidities and atherosclerotic burden, patients have a 5-year risk of up to 20% for MI, ischemic stroke, or death. A proportion of this risk is attributable to the inflammatory drivers in atherosclerosis, often referred to as the residual inflammatory risk.

0 1132 0
The fourth generation Da Vinci surgery brings new hope to it

The 4th generation Da Vinci surgical robot represents the highest level of today’s surgical robot: freely movable "arm", 3D high-definition image and human-computer interaction design of the console, making this operation the "Everest" that thoracic surgery experts are competing to climb.

0 423 0
Cardiac CT: A New Frontier in Advocating for Women’s Cardiovascular Health

Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of morbidity and mortality in women in the United States and worldwide.

0 514 0